{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P01308",
      "entity_text" : "insulin",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:445154",
      "entity_text" : "resveratrol",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "XREF_BIBR A meta-analysis of 11 studies indicated that resveratrol consumption significantly reduces fasting glucose, insulin, glycated hemoglobin levels, and insulin resistance in diabetic participants, whereas it has no effect on the glycemic profile of nondiabetic persons.",
  "reading_complete" : "2020-08-03T10:21:01Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T10:18:54Z",
  "trigger" : "reduces",
  "evidence" : [ "resveratrol consumption significantly reduces fasting glucose, insulin" ],
  "pmc_id" : "5914347",
  "score" : 0
}